2013•Zhongguo jiceng yiyaoRequires access

Effect of insulin glargine combined with acarbose in the treatment of type 2 diabetes mellitus

Caiqin Bai

Open publisher page 0 citations

Abstract

Objective To explore the clinical effect of insulin glargine combined with acarbose in treatment of type 2 diabetes mellitus(T2DM).Methods 189 T2DM patients were randomly divided into combined treatment group and the control group by digital table.Two groups were given the same basic treatment,combined treatment group was given glargine insulin(30R) and acarbose treatment,control group was given insulin glargine(30R) treatment.Clinical efficacy was compared between the two groups.Results After 3 months of treatment,two groups of patients after treatment,FPG and 2h glucose were improved (t =1.987,2.632,2.009,2.687,all P < 0.05).In combined treatment group,2b glucose after the meal [(7.3 ± 2.7)mmol/L] and effective rate(97.9%) were better than the control group[(8.7 ± 4.1) mmol/L,89.4%] (t =2.687,x2 =13.25,all P < 0.05).Conclusion Insulin glargine combined with acarbose in the treatment of T2DM had stable and reliable therapeutic effect. Key words: Type 2 diabetes mellitus ;  Human insulin isophane;  Acarbose

About this research paper

What this paper is about

Objective To explore the clinical effect of insulin glargine combined with acarbose in treatment of type 2 diabetes mellitus(T2DM).Methods 189 T2DM patients were randomly divided into combined treatment group and the control group by digital table.Two groups were given the same basic treatment,combined treatment group was given glargine insulin(30R) and acarbose treatment,control group was given insulin glargine(30R) treatment.Clinical efficacy was compared between the two groups.Results After 3 months of treatment,two groups of patients after treatment,FPG and 2h glucose were improved (t =1.987,2.632,2.009,2.687,all P < 0.05).In combined treatment group,2b glucose after the meal [(7.3 ± 2.7)mmol/L] and effective rate(97.9%) were better than the control group[(8.7 ± 4.1) mmol/L,89.4%] (t =2.687,x2 =13.25,all P < 0.05).Conclusion Insulin glargine combined with acarbose in the treatment of T2DM had stable and reliable therapeutic effect. Key words: Type 2 diabetes mellitus ;  Human insulin isophane;  Acarbose

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical effect of insulin glargine combined with acarbose in treatment of type 2 diabetes mellitus(T2DM).Methods 189 T2DM patients were randomly divided into combined treatment group and the control group by digital table.Two groups were given the same basic treatment,combined treatment group was given glargine insulin(30R) and acarbose treatment,control group was given insulin glargine(30R) treatment.Clinical efficacy was compared between the two groups.Results After 3 months of treatment,two groups of patients after treatment,FPG and 2h glucose were improved (t =1.987,2.632,2.009,2.687,all P < 0.05).In combined treatment group,2b glucose after the meal [(7.3 ± 2.7)mmol/L] and effective rate(97.9%) were better than the control group[(8.7 ± 4.1) mmol/L,89.4%] (t =2.687,x2 =13.25,all P < 0.05).Conclusion Insulin glargine combined with acarbose in the treatment of T2DM had stable and reliable therapeutic effect. Key words: Type 2 diabetes mellitus ;  Human insulin isophane;  Acarbose

Key concepts: Acarbose, Medicine, Insulin glargine, Internal medicine, Type 2 Diabetes Mellitus, Endocrinology, Insulin, Type 2 diabetes

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of insulin glargine combined with acarbose in the treatment of type 2 diabetes mellitus — Research Paper | ScholarLens